Biomet Inactive 10-Q2010 Q2 Quarterly report

Filed: 14 Jan 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accrual, acknowledged, Affordable, Alpina, alter, Anchor, arrange, arrangement, asserted, Athough, attached, Avantage, Bello, Biolox, Biomaterial, capability, certainty, clarification, clarified, clarify, client, closer, Cobalt, concentration, confidence, consideration, contravention, Copeland, CPG, creation, Cup, Dal, delta, Diagnostic, director, Distal, downturn, education, Encode, enrolled, evidenced, exclusive, Exhibit, EZLoc, facilitating, foregoing, Fracture, Gentle, Greece, handling, HealthTrust, III, impression, incorporated, indemnitor, ineffective, internationally, Italy, joining, JuggerKnot, literature, McVeigh, Michael, MV, national, organization, Oriented, OrthoPak, OSSEOTITE, passed, pecuniary, Pediatric, PEPM, platform, point, power, priority, Protection, provision, purport, pushed, qualified, relevant, responded, shift, shipping, Spain, SpinalPak, standard, subrogated, superseded, tertiary, text, tranche, Tray, Trust, Turkey, unclear, Unicompartmental, unpaid, VL, ZipTight

Removed: AccuVision, acquiree, acquirer, agreeing, amendment, ARB, assumed, Ballista, bankruptcy, Bulletin, compensate, credentialed, credentialing, deconsolidation, disclose, dismissal, EITF, enable, enhanced, evaluate, extension, failed, FIN, finance, force, fraud, FSP, identifiable, ill, implanted, inappropriately, intended, interpretation, invasive, jury, knew, leaving, lost, McNair, minimally, motivated, negligence, negligently, noncontrolling, OsteoGen, ownership, pain, Pedicle, prohibited, properly, prospectively, rejected, retained, revised, spent, SpF, stimulator, strict, suffering, sustained, Topic, trained, trial, uninsured, upstream, venture, violating, warn, warranty

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Biomet similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

SECTION 1350 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER

AND CHIEF FINANCIAL OFFICER

The undersigned, the Chief Executive Officer and the Chief Financial Officer of Biomet, Inc. (the “Company”), each hereby certifies pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge on the date hereof:

(a) The Quarterly Report on Form 10-Q of the Company for the Quarter Ended November 30, 2009 filed on the date hereof with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b) Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


January 14, 2010				/S/ JEFFREY R. BINDER
				Jeffrey R. Binder
				President and Chief Executive Officer

January 14, 2010				/S/ DANIEL P. FLORIN
				Daniel P. Florin
				Senior Vice President and Chief Financial Officer

The foregoing certification is being furnished to the Securities and Exchange Commission as an exhibit to the Form 10-Q and shall not be deemed to be considered filed as part of the Form 10-Q.